Ranbaxy's Woes Add $900 Million to U.S. Heart Drug Costs

... a single generic version of a named drug leads to a price drop of 30 to 50 percent, according to IMS Health Inc., a Danbury, Connecticut-based consulting firm. After six months, when other drugmakers can start making their own copies, the price ...



via Danbury Newswire http://ift.tt/1iR3pYn